US OptionsDetailed Quotes
CIEN240920P52500
- 2.20
- +0.70+46.67%
15min DelayClose Sep 6 16:00 ET
2.20High1.70Low
1.70Open1.50Pre Close16 Volume478 Open Interest52.50Strike Price2.87KTurnover35.27%IV1.68%PremiumSep 20, 2024Expiry Date1.34Intrinsic Value100Multiplier12DDays to Expiry0.86Extrinsic Value100Contract SizeAmericanOptions Type-0.6346Delta0.1137Gamma24.66Leverage Ratio-0.0470Theta-0.0100Rho-15.65Eff Leverage0.0356Vega
Ciena Stock Discussion
Sign in to post a comment
Morning Movers
Gapping up
$Citigroup (C.US)$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$Blackrock (BLK.US)$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life (GL.US)$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...
Gapping up
$Citigroup (C.US)$ shares increased by more than 2% after the bank reported revenue of $21.1 billion, surpassing analysts' expectations.
$Blackrock (BLK.US)$ 's stock grew by 2% following a quarterly report that exceeded expectations, with earnings per share of $9.81 on revenue of $4.73 billion.
$Globe Life (GL.US)$ shares surged approximately 9% in extended trading on Friday, recovering from a more than 50%...
27
1
Despite lukewarm market response, Ciena's earnings potential may be stronger than perceived due to robust free cash flow and higher earnings per share. A comprehensive understanding of the company's performance requires more factors to be considered.
2
Despite Ciena's reinvestment of its capital, the returns it's generating haven't increased. Given the underlying trends, it's unlikely to be a multi-bagger going forward.
Daryanani predicts Ciena's earnings per share could reach $3.50 or more in fiscal 2024, surpassing the $2.90 consensus estimate. He views Ciena as a 'very attractive asset', the best-in-class optical vendor, and expects the stock to rise due to a 'series of beat and raises coupled with multiple expansion'.
The market's prediction of continued strong earnings growth is reflected in Ciena's high P/E ratio. Shareholders' reluctance to sell the stock indicates an anticipation for a prospering future, making a significant share price drop unlikely.
Ciena's revenue spike may signify aptly handling pandemic-induced demand. The CEO's aim to corner cloud customers aligns with market trends. However, the low telecom demand reflects an industry-wide tendency.
Though Ciena's EPS fall does not align with share price variation, its long-term performance is praised. Metrics like revenue growth rate may be more crucial to investors.
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Ciena (CIEN.US)$ - up 9.1%
2. $Okta (OKTA.US)$ - up 6.0%
3. $UGI Corp (UGI.US)$ - up 5.5%
4. $Shopify (SHOP.US)$ - up 5.4%
5. $UBS Group (UBS.US)$ - up 3.8%
6. $Salesforce (CRM.US)$ - up 2.6%
7. $KE Holdings (BEKE.US)$ - up 2.5%
8. $CrowdStrike (CRWD.US)$ - up 2.3%
9. $MINISO (MNSO.US)$ - up...
Gap Ups
1. $Ciena (CIEN.US)$ - up 9.1%
2. $Okta (OKTA.US)$ - up 6.0%
3. $UGI Corp (UGI.US)$ - up 5.5%
4. $Shopify (SHOP.US)$ - up 5.4%
5. $UBS Group (UBS.US)$ - up 3.8%
6. $Salesforce (CRM.US)$ - up 2.6%
7. $KE Holdings (BEKE.US)$ - up 2.5%
8. $CrowdStrike (CRWD.US)$ - up 2.3%
9. $MINISO (MNSO.US)$ - up...
+17
14
4
Pre-Market Stock Movers
Gapping up
$Salesforce (CRM.US)$ jumped 6.2% following its earnings beat after the bell Wednesday. Adjusted earnings per share came in at $2.12 for the second quarter, versus the consensus estimate of $1.90, per Refinitiv. Revenue was $8.60 billion, topping the $8.53 expected. Goldman Sachs subsequently hiked its price target by $15 to $340 a share, suggestions 58% upside.
$UBS Group (UBS.US)$ popp...
Gapping up
$Salesforce (CRM.US)$ jumped 6.2% following its earnings beat after the bell Wednesday. Adjusted earnings per share came in at $2.12 for the second quarter, versus the consensus estimate of $1.90, per Refinitiv. Revenue was $8.60 billion, topping the $8.53 expected. Goldman Sachs subsequently hiked its price target by $15 to $340 a share, suggestions 58% upside.
$UBS Group (UBS.US)$ popp...
24
1
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $ACADIA Pharmaceuticals (ACAD.US)$ - up 24.7%
2. $Elanco Animal Health (ELAN.US)$ - up 11.7%
3. $UnitedHealth (UNH.US)$ - up 7.2%
4. $Elevance Health (ELV.US)$ - up 5.0%
5. $The Cigna Group (CI.US)$ - up 4.7%
6. $Genmab (GMAB.US)$ - up 3.3%
7. $Centene (CNC.US)$ - up 3.1%
8. $Molina Healthcare (MOH.US)$ - up 3.0%...
Gap Ups
1. $ACADIA Pharmaceuticals (ACAD.US)$ - up 24.7%
2. $Elanco Animal Health (ELAN.US)$ - up 11.7%
3. $UnitedHealth (UNH.US)$ - up 7.2%
4. $Elevance Health (ELV.US)$ - up 5.0%
5. $The Cigna Group (CI.US)$ - up 4.7%
6. $Genmab (GMAB.US)$ - up 3.3%
7. $Centene (CNC.US)$ - up 3.1%
8. $Molina Healthcare (MOH.US)$ - up 3.0%...
+16
9
1
No comment yet
Peanny : Based on Lies…. The truth is on its way.